Lack of sedation: Fatal Forty DDI: Midazolam, carbamazepine interaction, CYP3A4

Erica D. Wittwer, Juraj Sprung, Wayne T. Nicholson

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This case discusses a pharmacokinetic interaction between midazolam and carbamazepine. Midazolam is a cytochrome P450 3A4 substrate and carbamazepine is a 3A4 inducer. Coadministration signifi cantly decreases the sedative effects of oral midazolam.

Original languageEnglish (US)
Title of host publicationA Case Approach to Perioperative Drug-Drug Interactions
PublisherSpringer New York
Pages369-372
Number of pages4
ISBN (Print)9781461474951, 9781461474944
DOIs
StatePublished - Sep 15 2015

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Lack of sedation: Fatal Forty DDI: Midazolam, carbamazepine interaction, CYP3A4'. Together they form a unique fingerprint.

Cite this